Il­lus­tri­ous Cam­bridge sci­en­tists join forces with $129M fund to bet on long plays in biotech

The lat­est tech-fo­cused fund to set up shop in the UK fea­tures an un­con­ven­tion­al group of part­ners: eight promi­nent sci­en­tists from Cam­bridge who have co-found­ed and put their own mon­ey in­to the $129 mil­lion (£100 mil­lion) fund.

Ahren In­no­va­tion Cap­i­tal made its de­but in May, lead­ing a $30 mil­lion Se­ries C for epi­ge­net­ics-based di­ag­nos­tics and ther­a­peu­tics com­pa­ny Cam­bridge Epi­genetix. Its fu­ture in­vest­ments will lie in four over­lap­ping fields: the brain and AI; ge­net­ics and biotech­nol­o­gy; space and ro­bot­ics; and en­er­gy and en­vi­ron­men­tal tech­nolo­gies, the Fi­nan­cial Times re­port­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER